BILL ANALYSIS

HR8137

BULLISH

To amend the Internal Revenue Code of 1986 to establish tax credits for the production of, and investment in, certain renewable materials.

HR8137 (To amend the Internal Revenue Code of 1986 to establish tax credits for the production of, and investment in, certain renewable materials.) has been assessed with a bullish outlook for investors. This legislation directly affects Archer-Daniels-Midland ($ADM). The primary sectors impacted are Agriculture, Materials and Manufacturing. View the full bill text on Congress.gov.

bullish

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

HR8137 provides a $0.10/lb tax credit for domestic biomass-derived renewable materials, directly improving producer margins.

ADM is the most directly impacted major public company, with large-scale U.S. biobased chemical production from corn and soy.

Bill is in early stages (referred to Ways & Means) with a moderate probability of passage within the 119th Congress as part of a broader tax or clean energy package.

How HR8137 Affects the Market

ADM's sharp 8.58% 7-day rally to $75.17, just $0.30 from its 52-week high, suggests the market is already pricing in some probability of favorable biobased policy outcomes. The $0.10/lb credit, if enacted, would provide direct margin lift to ADM's bioproducts segment, which has been a focus area for the company's growth strategy. Investors should monitor Ways & Means committee scheduling for markup; any hearing or floor action on HR8137 or similar tax credit bills would be a positive catalyst for ADM. In the absence of legislative progress, the stock's recent rally may partially unwind as pure sentiment fades.

Bill Details

Metric	Value
Bill Number	HR8137
Market Sentiment	bullish
Event Date	March 27, 2026
Affected Sectors	Agriculture, Materials, Manufacturing
Affected Stocks	Archer-Daniels-Midland ($ADM)
Source	View on Congress.gov →

Summary

HR8137 introduces a $0.10/lb tax credit for domestic production of renewable materials from biomass. ADM, a major producer of biobased chemicals from corn and soy in the U.S., is positioned to be a direct beneficiary. The stock has rallied 8.58% in the past 7 days to $75.17, nearing its 52-week high of $75.47, with the bill's introduction on March 27 as a likely catalyst.

Full AI Market Analysis

1) WHAT HAPPENED: On March 27, 2026, Rep. Fischbach (R-MN) introduced HR8137 in the House. The bill was referred to the Committee on Ways and Means, the tax-writing committee. It remains in early-stage status — not yet marked up, voted on, or passed by either chamber. 2) THE MONEY TRAIL: HR8137 does not appropriate funds. It creates a new Section 45BB in the Internal Revenue Code, authorizing a production tax credit of $0.10 per pound of qualified renewable material produced at a U.S. facility from biomass. The credit is calculated against the taxpayer's income tax liability under Section 38. This is a direct margin subsidy: every pound of qualifying production reduces tax liability by $0.10, effectively increasing after-tax profit by that amount per pound. Total foregone tax revenue (cost to Treasury) depends on industry production volume — if the sector produces 1 billion pounds annually, the annual fiscal cost is ~$100 million. 3) STRUCTURAL WINNERS: Archer-Daniels-Midland Company ($ADM) is the most direct beneficiary among public companies. ADM operates large corn wet mills (Cedar Rapids, IA; Decatur, IL; Clinton, IA) and soybean crush facilities that produce biobased chemicals (propylene glycol, glycerin, ethanol derivatives, biopolymers, industrial acids) that fall under the bill's qualified renewable material definition. The $0.10/lb credit boosts margins on existing production and improves economics for expanding capacity in biobased chemicals. Other potential beneficiaries include pure-play biobased chemical firms not yet public or smaller market caps; among large caps, $ADM has the most direct and material exposure. 4) MARKET DATA ANALYSIS: ADM has rallied sharply in the final week of April. From a close of $70.54 on April 27 to $75.17 on April 30 is +6.6% in three trading days. The 7-day change is +8.58%, and the stock is now just $0.30 below its 52-week high of $75.47. This price action coincides with the April 28-30 period and suggests the market is pricing in a higher probability of favorable biobased policy outcomes, including HR8137 potential passage or broader support for the bioeconomy sector. The 30-day change of +3.41% shows the move accelerated sharply in the last week. 5) TIMELINE: HR8137 is at the earliest legislative stage — referred to Ways & Means. Next steps: committee markup (could take months to never), then House floor vote if reported out. A companion bill in the Senate has not been introduced. Current Congress is the 119th (2025-2027), so this bill has until January 2027 to pass. Tax credits with bipartisan appeal (rural agricultural states, climate/factory innovation) have a moderate probability of being enacted as part of a broader tax extenders or clean energy package. No immediate floor action is scheduled.